Summary: The present investigation was carried out to determine the extent to which muscarinic acetylcholine receptors (mAChRs) in vascular and perivascular struc tures were colocalized with glial fibrillary acidic protein (GFAP)-positive structures. To this aim, an immunocy tochemical approach on free-floating cryosections and isolated microvessels obtained from rat brain was per formed to study the possible colocalization of immuno staining with the anti-mAChR protein antibody (M35) and an anti-GF AP antibody. Double-labeling experiments were carried out by fluorescent techniques. Confocal mi croscopic observations of GF AP and M35 immunoreac tivities on free-floating sections showed a high degree of colocalization on astrocyte processes associated with large vessels or capillaries. This pattern suggests that muscarinic receptors are associated with astrocytic end feet. Confocal microscopic observations of immunoreac tivity from isolated cerebral microvessels strengthen this conclusion since double-labeling of M35 and GFAP showed that perivascular astrocytic structures remained
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attached to the isolated microvessels and were present on vascular segments showing M35 immunoreactivity. In an other set of experiments, the specific binding of r3HJqui nuclidinylbenzylate (eHlQNB) to isolated microvessel membrane preparations from cerebral cortex, caudate nu cleus, thalamus, and cerebellum showed that a constant binding yield (20% in b0vine and 40% in rat) was ob served for microvessels compared with the corresponding brain region. According to our immunocytochemical re sults, the astrocytic membrane remaining attached to mi crovessels may account for the majority of the muscarinic binding to isolated microvessels. [3HJQNB binding values found in isolated microvessels cannot therefore be con sidered as artifacts without any link with vascular func tion. Taken together, the present study strengthens the idea that the muscarinic receptors may be implicated in the functional relationship between glial and vascular structures. Key Words: Astrocytes-Binding-Cerebral microvessels-Confocal microscopy-Immunofluores cence-Isolated microvessels-Muscarinic receptors.
ament protein, revealed that almost all GFAP labeled glial cells were immunostained for M35 (Van der Zee et aI., 1993) . In the cerebral cortex, this pattern has been well characterized in astro cytic endfeet surrounding the intraparenchymal vessels, which suggests that muscarinic receptors may be involved in a functional relationship be tween glial and vascular structures. This function may be suggested from the role played by astro cytes in the regulation of the brain ionic microenvi ronment, transmitter uptake from the extracellular space, reactive gliosis, and/or neuronal support (Henn and Hamberger, 1971; Walz, 1989; Malhotra et aI., 1990; Barres, 1991) . Muscarinic binding to cultured astrocytes has been characterized (Repke and Maderspach, 1982; Murphy et aI., 1986; Mur phy and Pearce, 1987; Hosli et aI., 1988) ; however, these data did not take into account the local vari ations occurring over the astrocytic plasma mem brane. The purpose of the present work was to de termine if muscarinic receptors are present in sig nificant amounts around vessel walls in the brain. The working hypothesis is that muscarinic binding to isolated brain microvessels is due mainly to as trocytic processes attached to the samples. Several authors have demonstrated the presence of musca rinic cholinergic receptors on cerebral arteries, in cluding intraparenchymal vessels (Estrada and Krause, 1982; Estrada et aI., 1983; Grammas et aI., 1983) ; however, the localization remains controver sial. It has been claimed that perivascular structures remaining attached to isolated microvessels may ac count for a significant proportion of the binding to such preparations (Harik et aI., 1981) . Such vascu lar preparations, isolated by mechanical procedures (density gradients and/or filtration), consist of en dothelial cells surrounded by a basal lamina, peri cytes, or smooth muscle and perivascular elements such as nerve endings and astrocyte processes (Suddith et aI., 1980; White et aI., 1981; Arneric et aI., 1988) . We therefore tested this isolation method used to assess for the presence of astrocytic pro cesses on the isolated microvessels and their colo calization with muscarinic receptors. To that aim, we compared by immunocytochemistry the distri bution pattern of mAChR protein (Andre et aI., 1983 (Andre et aI., , 1984 (Andre et aI., , 1987 and GFAP a�ound the c ' erebral microvasculature (Matsuyama et aI., 1988; Van der Zee et aI., 1989 , 1991 , 1992a on isolated microves sels and free-floating brain sections. To corroborate the immunological studies, the density of muscarin ic binding has been determined using eH]quinuclid inylbenzylate (eH]QNB) as ligand in bovine and rat microvessels isolated from different brain regions and compared with the parenchymal binding den sity of these regions.
MATERIALS AND METHODS

Isolation of cerebral microvessels
Microvessels were isolated from bovine or rat brain by the same procedure. Brains from male Wistar rats (150--200 g; Charles River France) were rapidly removed from the skull, the pial membranes were discarded, and the cortex was separated for microvessel isolation. Bovine brains freshly obtained from the local slaughterhouse were placed in ice-cold phosphate-buffered saline (PBS) solution for transport to the laboratory. Cerebral intra parenchymal microvessel fractions were immediately prepared from various brain regions (cortex, caudate nu cleus, thalamus, and cerebellum). The initial quantity of tissue used depended on the corresponding QNB activity measured, Brain samples were minced and gently homogenized in ice-cold PBS at pH 7.4 (NaCI 120 mM, KC12.7 mM in 10 mM phosphate buffer) by 10 up-and-down strokes in a Kontes glass homogenizer using a loosely fitting pestle (76-to 152-JLm clearance). The homogenate was filtered through a nylon mesh screen (120 JLm), and the material remaining on the filter was extensively washed with a stream of cold buffer. These filtration and washing operations were repeated 10 times, the filter res idue was centrifuged (1,000 R, 20 min) in PBS containing 13% dextran, and the pellet was centrifuged again. In a preliminary experiment, a third centrifugation was per formed to check the efficiency of the isolation procedure. Isolated microvessels contained in the pellet were resus pended in a medium containing 0.5 mM Tris and 0.25 M saccharose (pH 7.4).
Crude membrane fractions were prepared from the iso lated microvessels and the original homogenate. Samples were homogenized during 30 s in Tris-saccharose buffer with a tissue grinder (Ultra-Turrax) and centrifuged at 800 g for 10 min to remove cellular debris and large vessel fragments not disrupted by homogenization. The result ant supernatant was centrifuged at 27,000 g for 37 min. The pellet obtained was resuspended in PBS to a final concentration of 25-100 JLg proteinllOO JLI. The protein content of the various samples was determined according to the method of Lowry et al. (1951) (Sigma protein assay kit).
Light microscopy
Cortical homogenates and the resulting vascular frac tions of bovine cerebral microvessels were examined by light microscopy for composition and purity. Samples (50 JLI) spread onto gelatin (1 % )-coated slides were allowed to dry at room temperature. The tissue was postfixed with 4% paraformaldehyde in 0.1 M PBS (pH 7.4) for 10 min and stained with 1% cresyl violet. The samples were mounted under a coverslip and examined under bright field microscopy with a Leitz Laborlux microscope. Three random fields were photographed for each prepa ration at a final magnification of 40x. Photographs were analyzed using a computer image analyzer (Histoperi color; Numelec). Noneliminated parenchymal elements, arterioles, and capillaries were delineated with ajoystick controlled cursor. and the relative surface of the different elements was calculated.
Choline acetyltransferase assay
Cortical homogenates and the resulting vascular frac tions were prepared according to the procedure of Dau phin et al. (1991) . The samples were sonicated for 30 s in 0.5% Triton X-IOO and 10 mM ethylenediaminetetra acetate (pH 7.4) and centrifuged at 7,000 g for 5 min. Choline acetyltransferase (ChAT) activity was measured in the supernatants according to the procedure of Fon num (1975) as modified by Dietz and Salvaterra (1980) , The yield of ChAT activity in the supernatant was checked. All the ChAT activity measured in sonicated samples before centrifugation was recovered in the super natant. Supernatant fractions (10 JLI) were added to 10 JLl of an assay mixture containing 0.1 mM [14C]acetyl-CoA (60 mCi/mmol), 0.6 M NaCI, 0.1 M sodium phosphate buffer (pH 7.4), 16 mM choline chloride, 0.2 mM eserine sulfate, and 0.3 mM S-acetyl-CoA. Incubations were car ried out for 15 min at 37°C. Each assay was performed in triplicate. The reaction was stopped when the samples were placed in ice. The ['4C]ACh formed was extracted with sodium tetraphenylboron and the radioactivity was determined by liquid scintillation (lnstagel. Packard).
'Y-Glutamyltranspeptidase activity ,),-Glutamyltranspeptidase (,),-GTP) activity was mea sured on cortical homogenates and the resulting vascular fractions according to the method of Persijn and Van der Slik (1976) using 2.9 mM L-,),-glutamyl carboxy-3-nitro-4-anilide (Boehringer Mannheim enzymatic assay kit) as substrate. The changes in absorbance of the samples were followed at 405 nm during 3 min at room temperature (RT).
Immunocytochemical procedure for free-floating cryosections
Adult male Wistar rats (250-300 g) were used. First, the animals were deeply anesthetized with 4% halothane. Brain fixation was carried out by transcardial perfusion with 300 ml fixative composed of 2-3% paraformalde hyde, 0.05% glutaraldehyde, and 0.2% picric acid in 0.1 M PBS at pH 7.4 at a perfusion rate of 20 ml/min. The brains were removed from the skull and cryoprotected for 48 h at 4°C in 30% sucrose in 0.1 M PBS. Subsequently, 50-fLm sections were made with a freezing microtome. mAChRs were visualized by means of the monoclonal antibody M35. Extensive descriptions of the production, characterization, and immunocytochemical applications of the M35 antibody have been made previously (Andre et a!., 1984; Leiber et a!., 1984) . It has been shown that this antibody displays agonist-like activity, i.e., induces cy clic nucleotide changes that are inhibited by atropine, and is unable to discriminate between the muscarinic receptor subtypes (Leiber et a!., 1984; Vasudevan et aI., 1991 ; Van der Zee et a!., 1992h). Double-labeling experiments were carried out with fluorescent techniques and were per formed by sequential incubation of the sections with each of the primary antibodies. Free-floating cryosections were incubated overnight with mouse monoclonal mAChR antibody (M35 IgM, 1:500; Chemunex) at 4°C with gentle movement, followed by biotinylated goat anti mouse IgM (fL-chain directed, I :50; Sigma) for 2 h at RT and fluorescein isothiocyanate (FlTC)-conjugated streptavidin (1:50; Boehringer) for 2 h at RT. Upon com pletion of the M35 staining, the sections were incubated overnight at 4°C with rabbit monoclonal GF AP antibody (GF AP IgG, I :50; Sigma) followed by treatment with tet ramethylrhodamine isothiocyanate (TRITC)-labeled goat anti-rabbit IgG (1 :50; Sigma) for 2 h at RT.
Immunocytochemical procedure for isolated microvessels mAChRs were visualized by means of the monoclonal antibody M35. Antibodies against von Wille brand (Factor VIlI)-related antigen and GFAP were respectively used to characterize endothelial cells and glial fragments. Dou ble-labeling experiments for the study of colocalization of M35/Factor VIII and M35/GFAP were carried out with fluorescence techniques. The findings presented here were obtained from Wistar rats. The vascular fraction (50 fLl) was deposited in slide wells. After drying under vac uum for 2 h, 30 min, the tissues were fixed in methanol! acetone (1:1) at 4°C for 5 min, air dried, and frozen at -20°C. For dual labeling, the tissues were exposed over night at 4°C in the primary antibody solution (PBS/O.l % Triton X-IOO) containing mouse monoclonal mAChR an tibody (M35 IgM, 1 :200; Chemunex) and rabbit monoclo-J Cereb Blood Floit' Metab, Vol. 15, No. 6, 1995 nal GF AP antibody (GF AP IgG, 1:50; Sigma) or rabbit anti-human von Willebrand factor antibody (Factor VIII IgG, I :50; Sigma). Following rinsing, the tissues were incubated for 2 h at RT in PBS containing FITC-Iabeled goat anti-mouse IgM (1: 100; Sigma) and TRITC-labeled goat anti-rabbit IgG (1 :50; Sigma).
In all immunostainings, the incubation medium used was PBS and the sections were rinsed at least three times for 15 min in PBS containing 0.1 % Triton X-100 and 3% normal goat serum between all incubation steps. All in cubations with fluorophore-coupled antibodies were per formed in the dark. After antibody processing, the prep arations were mounted in a medium containing mowiol (Calbiochem), glycerol. and N-propyl gallate at a final pH of 8.
Appropriate control experiments were performed by omission of either one or both primary antibodies while retaining both secondary antibodies in the incubation cy cle. In all cases the controls yielded negative results, i.e., absence of any detectable labeling, excluding the possi bility of possible cross-reactivity of secondary antisera during the incubation cycle.
Fluorescence microscopy and image analysis
Immunofluorescent preparations were examined using confocal laser-scanning microscopy (CLSM) (MRC-600 Biorad Microscience Division, U.K.), equipped with a krypton/argon mixed gas·15-mW laser. This laser emits in exact coalignment at wavelengths of 488 nm (blue), 568 nm (yellow), and 647 nm (red). The CLSM was associated with a Nikon optiphot microscope equipped with epi fluorescence objective. Image processing of the double labeled preparations under the CLSM was performed using simultaneous excitation at 488 and 568 nm. Epi fluorescence of FlTC and TRITC was simultaneously re corded through separate channels and merged with the all-pixels method. A series of plane images was collected at l-fLm intervals. The individual tomographs of each sec tion were then summed for projection with the "maxi mum pixel" method.
[3HJQNB binding assay For ['HJQNB binding assays, membrane samples of brain homogenate or isolated microvessels from cow or rat (25-100 fLg protein/IOO fLl) were incubated for 60 min at 37°C in PBS buffer (pH 7.4) with 1.25 nM eH]QNB (42 Ci/mmol; Amersham) in a final volume of 400 fLl. The incubation was terminated by the addition of 4 ml ice-cold buffer, and the content was filtered through Whatman GF/C filters under vacuum. The filters were rapidly rinsed four times with 4 ml cold buffer. Each binding determination was performed in duplicate. Nonspecific binding was determined in samples supplemented with 10 fLM atropine. The respective QNB and atropine concen trations were chosen to obtain saturation of specific sites. The filters were then dried, and the radioactivity was de termined in 10 ml of scintillator (filter count; Packard) in a liquid scintillation counter at 41 % efficiency.
Statistics
Values are expressed as means ± SD. The significance was assessed by means of an analysis of variance and Scheffe's t test. Differences between values were consid ered significant when p < 0.05.
RESULTS
Characterization of vascular fraction
The vascular fraction was examined by light mi croscopy to assess its composition and purity. Computer-assisted image analysis showed that the fraction was highly enriched in microvessels (96 ± 9%. n = 7). Contamination by nonvascular ele ments such as free parenchymal structures did not represent more than 4 ± 2% (n = 7) of the total sample. We have differentiated the capillaries from the other vessels on the basis of their size. The vessels were considered as capillaries when their diameter was 5-10 !-lm. Our preparation contained 88 ± 4% (n = 7) capillaries and 8 ± 4% (n = 7) arterioles and venules. The microvessel enrichment of the preparation was also assessed by measure ment of the ),-GTP activity. an enzyme marker of intraparenchymal brain vessels (Orlowsky et al.. 1974; Goldstein et al.. 1975; Williams et al.. 1980; Rowan and Maxwell. 198 1) (Table I ). The specific activity of ),-GTP was 13 times higher in the mi crovessel fraction than in the cortical homogenate. In contrast to ),-GTP activity. no significant ChAT activity was found in the vascular fraction (Table I) .
Confocal microscopic observations of immunoreactivity
The immunofluorescence study of free-floating sections showed patches of GFAP-immunoreactive astrocytes and associated proq:sses that te ' rminated mainly around large penetrating arteries (Fig. IA) . GF AP-positive astrocytes displayed clear labeling for M35 (Fig. IA) . A strong correlation between GF AP and M35 immunoreactivities was observed on the glia limitans (Fig. IA) . On the contrary. the arachnoid membrane showed M35-positive. GFAP negative immunoreactivity (Fig. IA) . M35 colocal ized with G F AP was seen on astrocytic processes associated with all size vessels from large intra- parenchymal vessels (Fig. IA) to capillaries (Fig.  IB) . M35 immunoreactivity alone was observed on both the luminal and the abluminal sides of pial ar tery walls (Fig. IA) . In contrast, colocalized M35 and GF AP immunoreactivity was observed on the abluminal side of capillary walls (Fig. lB) , but not in the endothelium. Immunofluorescence double labeling for M35 and GF AP evidenced a high degree of colocalization on arterioles and/or venules (Fig.  IC) . Only M35 immunoreactivity was seen on py ramidal neurons (Fig. ID) . Figure 2C represents a phase contrast view of the isolated microvessels (capillaries, arterioles, and venules) obtained after the isolation procedure. Im munostaining was carried out from such prepara tions. lmmunostaining on isolated microvessels was performed by two independent double-staining studies of Factor VIII with M35 and GF AP with M35. The first double-staining was used to observe M35 immunostaining on all the vessels of the prep aration revealed by endothelial immunoreactivity to Factor VIII-related antigen. Figure 2B shows the labeling of Factor VIII-related antigen. As shown in Fig. 2A . M35 immunoreactivity was located on large vessels rather than on capillaries. The second double-staining was used to study colocalization of GFAP and M35 immunoreactivity in the samples. GFAP immunofluorescence was seen principally on large vessels (Fig. 3B) . Fluorescent double-labeling for the muscarinic receptor antibody and GF AP an tibody showed that the immunostaining patterns were very similar (Fig. 3) .
eHJQNB binding to microvessel fraction
In a preliminary experiment performed with bo vine brains, we checked the purity of the prepara tion by measuring the eHlQNB binding site density in samples obtained after different steps in the pu rification procedure (Fig. 4) . The stability of the amount of QNB binding after the centrifugation step was considered as a test for the maximal puri fication that could be obtained by this procedure. Three successive centrifugations were used to pu rify the vascular fraction. No significant difference was found between the samples obtained after the second and the third centrifugation. For this reason, only two centrifugations were carried out in the fol lowing experiments.
The specific binding of [3HJQNB was determined in membrane preparations obtained from bovine ce rebral cortex, caudate nucleus, thalamus, and cer ebellar cortex using a ligand concentration of 1.25 nM. Significant quantities of specific QNB binding sites were found in microvessel fractions from all brain regions studied. The binding of [3HJQNB to 
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• 4, . microvessels isolated from four different regions of bovine brain showed a strong correlation between the density of binding sites on microvessels and the density in the original gray matter (Fig. 5) . By ex pressing the binding in the different vascular frac tions as a percentage of that found in the gray mat ter from the corresponding brain region for each sample, we found a mean value of �20%. The same specific binding experiment was carried out in membrane preparations obtained from rat cerebral cortex and cerebellum. The concentration of vascu lar binding sites represented �40% of the concen tration of the original homogenate for the two brain structures (cortex homogenate: 1,980 ± 42 fmoIlmg protein, n = 3; cortex microvessels: 750 ± 5 fmoIl mg protein, n = 2; cerebellum homogenate: 200 ± 30 fmoIlmg protein, n = 3; cerebellum microves sels: 92 ± 14 fmol/mg protein, n = 2). 
DISCUSSION
The microvessel preparation used in this study consisted mainly of capillaries (88%) and muscular walled vessels (8%). This proportion is in accor dance with previous studies using isolated rat (Goldstein et aI., 1975; Santos-Benito and Gonza lez, 1985) or bovine (Estrada et a\., 1983; Galea and Estrada, 199 1) capillaries. The 13-fold increase of ),-GTP activity measured in isolated microvessels as compared to whole-brain homogenate is in ac cordance with the values generally found for such preparations (Orlowsky et a\., 1974; Goldstein et aI., 1975; Williams et aI., 1980; Estrada et aI., 1983; Bradbury, 1984; Arneric et a\., 1988) . It confirms the high efficiency of the separation technique. The almost undetectable ChAT activity found in our mi crovessel preparation diverges from the measurable activity previously found in isolated microvessels (Hardebo et aI., 1977; Estrada and Krause, 1982; Arneric et aI., 1988) and capillary-enriched frac tions (Estrada et al., 1983; Gonzalez and Santos Benito, 1987 ) from different species. However, it should be stressed that the activity found by most workers did not exceed 20% of cortical gray matter values. Recently, Galea and Estrada (199 J) found that digestion of capillary-enriched fractions with collagenase followed by purification of the endothe lial cells resulted in a significant decrease of ChAT activity. A preferential nonendothelial origin of ChAT has also been reported in rabbit pial vessels, in which the enzyme activity was not modified after removal of the endothelium (Hamel et aI., 1987) . These results indicate that most of the ChAT activ ity measured in the microvessel fractions was not localized in endothelial cells but in perivascular cholinergic nerves. Arneric et aI. (1988) found that <5% of capillary endothelial cells were ChAT immunoreactive. The absence of ChAT activity in our preparation suggests that the isolation proce dure induced cytoplasmic leak from perivascular cells leading to loss of ChAT. It also indicates that there was negligible contamination by nonvascular debris. Light microscopic examination showed that this contamination did not exceed 4% of the total content of the preparation. Its cytological nature was not determined, but autoradiographic binding showed that, in contrast to most parenchymal ele ments of the homogenate, this debris did not specifically bind eH]QNB (results not shown). We therefore suggest that this contamination was es sentially due to white matter fragments. To determine the extent to which M35 immuno reactivity in vascular and perivascular structures was colocalized with GFAP-positive structures, we performed confocal microscopic observations of GF AP and M35 immunoreactivity on free-floating brain sections. The most striking feature was a high degree of colocalization around intraparenchymal vessels with an intense M35-positive fluorescence. Perforating arteries were more extensively envel oped by fluorescence than capillaries. This pattern is in accordance with previously published results (Matsuyama et aI., 1988; Van der Zee et aI., 1993) . Our immunological results suggest that muscarinic receptors are associated with astrocytic endfeet; however, a faint but significant M35-positive, GFAP-negative immunoreactivity was present in the walls of some vascular elements. Indeed, M35 immunoreactivity alone was more often seen in pial vessels and perforating arteries than in capillaries. This feature probably represents muscarinic recep tors associated with smooth muscle and/or endothe lial cells. It has been shown that the activation of muscarinic cholinergic receptors in endothelial cells (Tsukahara et aI., 1989 ) induces a vasodilatation ] " 100 ;;. (Furchgott and Zawadzki, 1980; Sercombe et aI., 1985; Dauphin and Hamel, 1990; Garcia-Villalon et aI., 1991) . These receptors are believed to modulate cerebral blood flow especially by acting on resis tance vessels. Since pial vessels are endowed with a rich network of autonomic nerve fibers (MacKenzie and Scatton, 1987; Edvinsson et aI., 1993) , such receptors could be involved in the parasympathetic cholinergic vasodilative pathway. Parasympathetic cholinergic fibers apparently do not innervate the intraparenchymal vessels, so that the muscarinic re ceptors associated with these vessels must be acti vated preferentially by fibers of intracerebral origin (Lacombe et aI., 1989; Linville and Arneric, 1991) .
The specific binding of eH]QNB to microvessel membrane preparations obtained from bovine cere bral cortex, caudate nucleus, thalamus, and cere bellar cortex showed significant quantities of bind ing sites. The constant amount of specific binding sites measured on microvessel fractions obtained after two or three purification steps by centrifuga tion is in accordance with their localiz&tion on iso lated microvessels. This conclusion is supported by the absence of QNB binding associated with paren chymal debris (see preceding). The binding in the different vascular fractions represented � 20% of that found in gray matter from the corresponding brain region, and similarly a constant binding ratio (40%) was also observed for microvessels isolated from rat cerebral cortex or cerebellum, indicating that this phenomenon was not linked to the animal species used. These data are not consistent with those reported by Estrada et al. (1983) who found a fairly constant amount of binding to isolated mi crovessels whatever the brain region studied. In our study, the correlation between the binding ratio in parenchymal gray matter and isolated microvessels was evidenced by comparing each set of values from individual brain samples. This method, in fact, demonstrates that the binding was due to perivas cular elements. Our confocal microscopic observations on immu noreactivity in isolated cerebral microvessels strengthen our observations on free-floating brain sections and the binding results. When all the ves sels in the preparation were identified by uniform staining of the endothelium with Factor VIII anti body, M35 immunoreactivity appeared to be lo cated preferentiallY in larger vessels (arterioles and venules). Double-labeling of M35 and GFAP showed that perivascular astrocytic structures re mained attached to the isolated microvessels and were present on all vascular segments showing M35 immunoreactivity. It is likely that the plasma mem branes and the cytoskeleton of astrocytic structures J Cereb Blood Flow Metab. Vol. 15, No.6, 1995 are tightly bound to the basal lamina of the vessels and were thus not eliminated by the separation pro cess. Since the same phenomenon may occur for perivascular fibers, the possibility that a fraction of the muscarinic receptors associated with isolated microvessels may reside on perivascular nerve membranes cannot be ruled out. It is thus likely that binding studies of muscarinic receptors in mi crovessel preparations estimate the binding site density on membranes of perivascular parenchymal elements.
Electron microscopic and immunohistochemical observations have shown that isolated microvessel preparations consist of endothelial cells surrounded by a basal lamina, pericytes, or smooth muscle cells and perivascular elements such as nerve endings and astrocytic processes (Harik et aI., 1981; White et aI., 198 1) . However, the presence of muscarinic receptors on these perivascular membranous struc tures has never been tested. Our results clearly show that these elements account for the majority of the muscarinic binding on isolated microvessels. It would be interesting to determine whether the colocalization of GF AP and muscarinic receptors is a specific' feature of perivascular glia or a general finding for activated astrocytes. The presence of functional mAChRs in astroglia has been estab lished by various studies using cultured glial cells (Repke and Maderspach, 1982; Murphy et aI., 1986; Murphy and Pearce, 1987; Hbsli et aI., 1988) . As trocytes are believed to play a potassium buffering role: Excess potassium ions liberated in the extra cellular space during neuronal activity may be elim inated by astrocytes (Kimelberg and Norenberg, 1989) . In relation with this function, an intense M35 but no GFAP immunoreactivity was also seen on the arachnoid membrane in the present experi ments. This is in accordance with a binding study (Lasbennes et aI., 1992) that evidenced a large quantity of muscarinic binding sites on this struc ture. We postulate that muscarinic receptors may be implicated in electrolytic regulation between the subarachnoid and subdural spaces. Astrocytic end feet may be implicated in the same function around the intraparenchymal vessels.
Other roles may be postulated for mAChRs on glial endfeet. Numerous physiological results indi cate a role for central cholinergic neurons in cortical vasodilatation observed after stimulation of differ ent cerebral regions such as the cerebellar fastigial nucleus (N akai et aI., 1983) or the telencephalic basal nucleus (Lacombe et aI., 1989) . There are also morphological studies in favor of a cholinergic control of the cerebral microcirculation. Several electron microscopy studies have shown ChAT-immunoreactive nerve endings or varicosities in proximity to rat cerebral cortex capillaries (Ecken stein and Baughman, 1984; Arneric et aI., 1988; Chedotal et aI., 1994) . This neurovascular apposi tion generally includes a glial layer, suggesting that mAChRs on astrocytes might be involved in the control of cerebral blood supply and/or the blood brain barrier. Two nonexclusive mechanisms can be suggested for the action of ACh on intracerebral microvessels: (a) Cholinergic nerve endings ap posed to the basal membrane could release ACh, which could act directly on the endothelial or mus cle cells; (b) ACh released could act on perivascular astrocytes, which might then release a factor influ encing the endothelial or muscle cells (the action of ACh on these cells would thus be indirect). Our immunohistochemical data are in favor of this latter mechanism, which could constitute the basis of neurovascular interactions in the cerebral cortex.
Our immunohistological studies on free-floating sections and isolated microvessels have demon strated the presence of muscarinic receptors on glial endfeet. The l3H]QNB binding to microvessels can be considered to be due mainly to muscarinic re ceptors on perivascular glial endfeet. The function mediated by these receptors remains largely un known, but their strategic localization around the vessels suggests some relation to vascular func tions.
